Elucidation of the effects of immunosuppressive drugs on SARS-CoV-2 genome replication and T cell response

Grant number: 21K08619

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2021
    2024
  • Known Financial Commitments (USD)

    $37,440
  • Funder

    KAKENHI
  • Principal Investigator

    Yuka Tanaka Unspecified
  • Research Location

    Japan
  • Lead Research Institution

    Hiroshima University
  • Research Priority Alignment

    N/A
  • Research Category

    Therapeutics research, development and implementation
  • Research Subcategory

    N/A
  • Special Interest Tags

    N/A
  • Study Type

    Unspecified
  • Clinical Trial Details

    N/A
  • Broad Policy Alignment

    Pending
  • Age Group

    Not Applicable
  • Vulnerable Population

    Not applicable
  • Occupations of Interest

    Not applicable

Abstract